Phase 3 clinical trial: Brain cancer vaccine shows promising results

Phase 3 clinical trial: Brain cancer vaccine shows promising results

byKing's College LondonOverall Survival for Patients With Recurrent Glioblastoma Kaplan-Meier plot comparing overall survival for patients with recurrent glioblastoma treated with autologous

Phase 3 clinical trial: Brain cancer vaccine shows promising results

byKing's College LondonOverall Survival for Patients With Recurrent Glioblastoma Kaplan-Meier plot comparing overall survival for patients with recurrent glioblastoma treated with autologous
Neurosurgery: new augmented reality technology helps to complete multiple surgeries

Neurosurgery: new augmented reality technology helps to complete multiple surgeries

Augmented reality accurate localization, assisting endoscopic cerebral hematoma removal surgeryThe Department of Neurosurgery (Digital/Secure Neurosurgery) of the East Campus accurately localized a

Neurosurgery: new augmented reality technology helps to complete multiple surgeries

Augmented reality accurate localization, assisting endoscopic cerebral hematoma removal surgeryThe Department of Neurosurgery (Digital/Secure Neurosurgery) of the East Campus accurately localized a
Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch
How Successful Is Immunotherapy for Breast Cancer?

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the
European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients
Who Gets Laryngeal (Voice Box) Cancer?

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al
Lung cancer cells covertly thrive in brain under guise of protection, study finds

Lung cancer cells covertly thrive in brain under guise of protection, study finds

by Krista Conger,Stanford University Medical CenterSmall cell lung cancer cells (green and blue) that metastasized to the brain in a laboratory mouse recruit brain cells called astrocytes (red)

Lung cancer cells covertly thrive in brain under guise of protection, study finds

by Krista Conger,Stanford University Medical CenterSmall cell lung cancer cells (green and blue) that metastasized to the brain in a laboratory mouse recruit brain cells called astrocytes (red)
Skin cancer: More people die from types that aren't melanoma, says surprise new finding

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W
New potential therapeutic approach for HER2-positive breast cancer discovered

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co
New study disentangles a long-standing link between inflammation and cancer progression

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk